Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells
Viruses · 2024
DOI: 10.3390/v16121958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Leslie Elsner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Oncolytic Viruses, Oncolytic Virotherapy, Enterovirus B, Human. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Aid, Wilhelm Sander Stiftung, Deutsche Krebshilfe.
Abstract (Originalsprache)
Recently, we demonstrated that the oncolytic Coxsackievirus B3 (CVB3) strain PD-H can be efficiently adapted to resistant colorectal cancer cells through dose-dependent passaging in colorectal cancer cells. However, the method is time-consuming, which limits its clinical applicability. Here, we investigated whether the manufacturing time of the adapted virus can be reduced by replacing the dose-based passaging with volume-based passaging. For this purpose, the murine colorectal carcinoma cell line MC38, resistant to PD-H-induced lysis, was initially infected with PD-H at 0.1 multiplicity of infection (MOI). For subsequent passages, 15–30 µL of a 1:10 dilution of the cell culture supernatant was transferred to fresh MC38 cells early after virus-induced cell lysis became visible. By virus passage 10, complete cell lysis of MC38 cells was achieved. Sequencing of the passage 10 virus (P-10) revealed two nucleotide substitutions in the 5′ UTR and six amino acid changes in the viral polyprotein compared to the PD-H founder. P-10, however, consisted of a heterogeneous virus population. Therefore, the detected mutations were introduced into the cDNA of PD-H, from which the recombinant virus PD-MC38 was generated. PD-MC38 exhibited significantly enhanced replication and lytic activity in MC38 cells compared to PD-H, whereas its oncolytic activity in other colorectal cancer cell lines was comparable to or even lower than that of PD-H. These findings demonstrate that volume-based passaging is suitable to generate tumor cell-specific adapted PD-H. Moreover, compared to the dose-dependent passaging, volume-based passaging significantly reduced the time required to generate the adapted virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany.
- Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), 13353 Berlin, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Berlin, 13092 Berlin, Germany.
ORCID-Profile: Sophie Van Linthout, Jens Kurreck, Henry Fechner
Förderung
- German Cancer Aid
- Wilhelm Sander Stiftung
- Deutsche Krebshilfe
- Wilhem Sander-Stiftung
Zitieren
APA
Elsner, L., Dieringer, B., Geisler, A., Girod, M., Van Linthout, S., Kurreck, J., & Fechner, H. (2024). Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells. Viruses. https://doi.org/10.3390/v16121958
Vancouver
Elsner L, Dieringer B, Geisler A, Girod M, Van Linthout S, Kurreck J, et al. Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells. Viruses. 2024. doi:10.3390/v16121958
BibTeX
@article{Elsner2024,
author = {Elsner, Leslie and Dieringer, Babette and Geisler, Anja and Girod, Maxim and Van Linthout, Sophie and Kurreck, Jens and Fechner, Henry},
title = {Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121958}
}
EUVIMED